CDKN2A and cancer: A further extension cohort of 16 samples of USARCs (Table S1) were sequenced to a mean target depth of 403× on a cancer gene exome panel covering 3 Mb of the genome, including intronic coverage of TP53, RB1, ATRX, and CDKN2A.